Detrusor Underactivity
11
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder.
EEP in Patients With Urodynamically Proven DU/DA
GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology
Can Acupoint Low Intensity Shockwave Therapy Improve Bladder Voiding Efficiency
Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB)
Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction
DU and BOO in Women With and Without Symptoms of VD
A Comparative Analysis of Portable Bladder Scanner to Determine Age/ Volume Specific Accuracy in 0-6 Years of Children
Detrusor Underactivity: Presentation and Urodynamic Characteristics
Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods
Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity